Nuvalent logo



Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.


Add photos to showcase Nuvalent’s culture


Add Nuvalent’s values

Insider experiences

Share your experience of working at Nuvalent

Christopher Turner
Chief Medical Officer
Deb Miller
Chief Legal Officer
Darlene Noci
SVP, Product Development & Regulatory Affairs
Joshua Horan
VP, Chemistry
Henry Pelish
VP, Biology
John Soglia
VP, Translational Development
Jessie Lin
VP, Corporate Strategy & Portfolio Management
Matthew Metivier
VP, Human Resources
Shannon Dauksis
Senior Director, Program Management
Kristi Byrnes
Director, Quality Assurance

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure